FORMYCON AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.75 EUR | -0.93% |
|
-1.04% | -24.20% |
| 04-25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FORMYCON AG | Other Biotechnology & Medical Research | -0.93% | -1.04% | -24.20% | -40.62% | +26.11% | 813M |  |  | |
- Stock Market
- Equities
- FYB Stock
- Charts Formycon AG
- Relative Strength Chart
